EUVIMEDEUVIMED entdecken
VergleichsstudieQuerschnittstudie

Cross-sectional study of long-term Health-Related Quality of Life in stage III melanoma patients receiving neo-adjuvant versus adjuvant immune checkpoint inhibitors

E A C Albers, M J Luijendijk, M Egeler, I Fraterman, M W Lucas, K M de Ligt, S B Schagen, C U Blank, L V van de Poll-Franse

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115710 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von E A C Albers und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Melanoma, Quality of Life, Neoadjuvant Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsMelanomaQuality of LifeNeoadjuvant TherapySkin NeoplasmsHumansMaleFemaleCross-Sectional StudiesMiddle AgedChemotherapy, AdjuvantAgedNeoplasm StagingAdult

Stichwörter der Autor:innen

Health-Related Quality of LifeImmune checkpoint inhibitionMelanomaNeoadjuvant

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen…
  • Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Psychology, University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands; Department of Hematology and Oncology…
  • Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Psychology, Tilburg University, Tilburg, the Netherlands. Electronic address: l.v…

Zitieren

APA

Albers, E. A. C., Luijendijk, M. J., Egeler, M., Fraterman, I., Lucas, M. W., de Ligt, K. M., Schagen, S. B., Blank, C. U., & van de Poll-Franse, L. V. (2025). Cross-sectional study of long-term Health-Related Quality of Life in stage III melanoma patients receiving neo-adjuvant versus adjuvant immune checkpoint inhibitors. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115710

Vancouver

Albers EAC, Luijendijk MJ, Egeler M, Fraterman I, Lucas MW, de Ligt KM, et al. Cross-sectional study of long-term Health-Related Quality of Life in stage III melanoma patients receiving neo-adjuvant versus adjuvant immune checkpoint inhibitors. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115710

BibTeX
@article{Albers2025,
  author = {Albers, E A C and Luijendijk, M J and Egeler, M and Fraterman, I and Lucas, M W and de Ligt, K M and Schagen, S B and Blank, C U and van de Poll-Franse, L V},
  title = {Cross-sectional study of long-term Health-Related Quality of Life in stage III melanoma patients receiving neo-adjuvant versus adjuvant immune checkpoint inhibitors},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115710}
}
Kostenlos starten →